Hepcidin in human iron disorders: therapeutic implications.
about
Treatment for anemia in people with AIDSDual Role of ROS as Signal and Stress Agents: Iron Tips the Balance in favor of Toxic EffectsDietary iron concentration may influence aging process by altering oxidative stress in tissues of adult ratsHepcidin regulates ferroportin expression and intracellular iron homeostasis of erythroblastsEffects of a single dose of oral iron on hepcidin concentrations in human urine and serum analyzed by a robust LC-MS/MS methodNon-coding keratin variants associate with liver fibrosis progression in patients with hemochromatosis.Non-HFE hemochromatosisRole of duodenal iron transporters and hepcidin in patients with alcoholic liver disease.Second round robin for plasma hepcidin methods: first steps toward harmonization.Silencing airway epithelial cell-derived hepcidin exacerbates sepsis induced acute lung injury.Association of hepcidin mRNA expression with hepatocyte iron accumulation and effects of antiviral therapy in chronic hepatitis C infection.Chronic administration of 2-acetylaminofluorene alters the cellular iron metabolism in rat liver.Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in miceLow Serum Hepcidin in Patients with Autoimmune Liver Diseases.Unraveling mechanisms regulating systemic iron homeostasis.Physiology and pathophysiology of iron in hemoglobin-associated diseases.Iron and steatohepatitis.Molecular diagnostic and pathogenesis of hereditary hemochromatosis.Hepcidin-minireview.Coupling heme and iron metabolism via ferritin H chain.Gluconeogenic signals regulate iron homeostasis via hepcidin in miceProanthocyanidin Protects Human Embryo Hepatocytes from Fluoride-Induced Oxidative Stress by Regulating Iron Metabolism.Effects of mouse hepcidin 1 treatment on osteoclast differentiation and intracellular iron concentration.A complex signaling network involving protein kinase CK2 is required for hepatitis C virus core protein-mediated modulation of the iron-regulatory hepcidin gene expression.Iron Metabolism and the Inflammatory Response.Deferasirox in patients with iron overload secondary to hereditary hemochromatosis: results of a 1-yr Phase 2 study.Effect of iron overload on furin expression in wild-type and β-thalassemic mice.Adaptation of iron transport and metabolism to acute high-altitude hypoxia in mountaineers.Study of serum hepcidin in hereditary hemolytic anemias.Hepcidin in Iron Homeostasis: Diagnostic and Therapeutic Implications in Type 2 Diabetes Mellitus Patients.CHOP-mediated hepcidin suppression modulates hepatic iron load.Iron stores assessment in alcoholic liver disease.Serum hepcidin levels and muscle iron proteins in humans injected with low- or high-dose erythropoietin.
P2860
Q24235994-BAE4E73D-AF7A-412D-AF2F-4745AA2B1458Q26752455-C6DDD475-840F-4739-8537-785502E8590FQ28396870-BA72C04F-5B34-480A-88CB-6AA0145934C6Q28585215-4250C2DC-74B6-4F27-8CC6-0FA389C6891CQ34003022-8086B623-C75A-4D7C-99BB-F8DC23B1B266Q34193306-43818F73-7A93-49BB-B81D-03D5554FC3F1Q34304892-AA9755DD-606B-48B2-A14B-F200BD8CA36AQ34336869-6458CAA5-B5BC-4EBC-BDB0-080A9E11613CQ34377416-5D63653D-FB84-483B-ABDE-934AE3F187ACQ34570105-1EEFCBD6-1FD8-43C0-A7DA-D5142F0A86FAQ34864591-44969569-5BF3-4236-A1A7-FB50328F0FBFQ35231099-D0598987-7C3E-43D8-BF15-A092AD5619C6Q35483789-084285E8-46DF-44BE-9E0B-CE3BCC9DA7F8Q35745075-7D49358F-FC89-49B7-B91E-51194A501768Q36828496-E3B4302E-CA77-4F0D-8D15-0BB2A96FB255Q37082896-12547233-D08A-4423-BFE8-9A54DE1DC8A8Q37982805-E1BF547C-575C-4BE3-B39D-6B210DD323BDQ37992618-CF8FD0CC-2D0F-40EB-9868-F65AB1C8F1F8Q38148547-FD51EBB7-2115-4D95-87B0-3FA695D05B2FQ38152477-2DE11ECE-AE24-47D0-BCF5-DB00F72023C7Q38789248-0DD2BFEF-E083-42B1-964D-25CACF3971A1Q38860659-51B37E72-E92A-4354-9890-234D1DC19CACQ38972072-CE62166A-640F-4502-9B75-5F36523CFE75Q39005729-669BECA1-3BBC-456C-838E-91449643FC7EQ39285336-410EDC30-CB0C-40F4-9553-D4EB75CF9D79Q41432463-682083EC-1652-40F2-899C-95855E4FD241Q41680629-4729947D-0415-47D4-8869-0281CBBDC313Q45140568-42074A01-9520-46BD-85A2-4CCEAFB5E62AQ46246165-F8AC7CCC-87A6-4AF9-B883-6913AB6F7BA4Q46261579-94EC218B-FB3F-4E55-A3B1-4C191B348B46Q46606674-D6E4C9D7-1B4E-431A-AB0B-ED6D90AB9AB9Q46832943-1DE93750-3303-4EC4-9BBA-2619309C9F59Q51071449-E3F27FD8-DED1-47FC-A8B9-393FE829053C
P2860
Hepcidin in human iron disorders: therapeutic implications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepcidin in human iron disorders: therapeutic implications.
@en
Hepcidin in human iron disorders: therapeutic implications.
@nl
type
label
Hepcidin in human iron disorders: therapeutic implications.
@en
Hepcidin in human iron disorders: therapeutic implications.
@nl
prefLabel
Hepcidin in human iron disorders: therapeutic implications.
@en
Hepcidin in human iron disorders: therapeutic implications.
@nl
P1476
Hepcidin in human iron disorders: therapeutic implications
@en
P2093
Antonello Pietrangelo
P304
P356
10.1016/J.JHEP.2010.08.004
P577
2010-08-26T00:00:00Z